Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
isocitrate dehydrogenase/рак
Линкът е запазен в клипборда
Страница 1 от 27 резултата
Use of isocitrate dehydrogenase 1 as a diagnostic and prognostic biomarker and therapeutic target for lung cancers
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
CROSS REFERENCE TO RELATED APPLICATIONS
The present application is a U.S. National Phase of International Patent Application Serial No. PCT/CN2012/081327, entitled "ISOCITRATE DEHYDROGENASE 1 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR LUNG CANCERS," filed on Sep. 13, 2012,
Use of isocitrate dehydrogenase 1 as a diagnostic and prognostic biomarker and therapeutic target for lung cancers
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
INCORPORATION BY REFERENCE OF ELECTRONICALLY SUBMITTED MATERIAL
Incorporated by reference in its entirety herein is a computer-readable nucleotide sequence listing submitted herewith and identified as follows: 3,201 bytes ASCII (Text) file named "Sequence_Listing_JEE15301PCTUSDIV," created Sep. 28,
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant iso citrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers.
Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF INVENTION
The present invention is directed to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of diseases or disorders associated with such mutant IDH proteins including cell-proliferation disorders and cancers. Specifically,
Най-пълната база данни за лечебни билки, подкрепена от науката
- Работи на 55 езика
- Билкови лекове, подкрепени от науката
- Разпознаване на билки по изображение
- Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
- Прочетете научни публикации, свързани с вашето търсене
- Търсете лечебни билки по техните ефекти
- Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите
Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания
